Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$70.57 USD
+0.20 (0.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $70.64 +0.07 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth B Momentum D VGM
Earnings News For LGND
-
Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?
-
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
-
Ligand: Q4 Earnings Snapshot
-
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
-
Ligand (LGND) Up 12.4% Since Last Earnings Report: Can It Continue?
-
Ligand (LGND) Beats on Q3 Earnings & Sales, Raises '23 View
-
Ligand: Q3 Earnings Snapshot
-
Ligand Reports Third Quarter 2023 Financial Results
-
Ligand Pharmaceuticals (LGND) Earnings Expected to Grow: Should You Buy?
-
Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?
-
Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings
-
Ligand Pharmaceuticals (LGND) Q2 Earnings Beat Estimates
-
Ligand: Q2 Earnings Snapshot
-
Ligand Reports Second Quarter 2023 Financial Results
-
Ligand (LGND) to Post Q2 Earnings: What's in Store?
-
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings
-
Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue Estimates
-
Ligand: Q1 Earnings Snapshot
-
Ligand's (LGND) Q4 Sales & Earnings Top, View Raised, Stock Up
-
Ligand Pharmaceuticals (LGND) Surpasses Q4 Earnings and Revenue Estimates
-
Ligand: Q4 Earnings Snapshot
-
Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
-
Ligand (LGND) Down 3% Since Last Earnings Report: Can It Rebound?
-
Ligand (LGND) Beats on Q3 Earnings, Lags Sales, Ups '22 Outlook
-
Ligand Pharmaceuticals (LGND) Misses Q3 Earnings Estimates